Ascendis Pharma A (ASND) Change in Inventory (2019 - 2026)

Ascendis Pharma A has reported Change in Inventory for 6 years, with the latest figure at -$15.0 million in Q1 2026.

• Quarterly Change in Inventory fell 661.89% year-over-year to -$15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.5 million (up 62.38% YoY) and the FY2025 annual result came in at -$6.9 million, up 92.56% from the prior year.
• Change in Inventory eased to -$15.0 million in Q1 2026 per ASND's latest filing, from $583185.8 in the prior quarter.
• Over five years, Change in Inventory peaked at $2.7 million in Q1 2025 and troughed at -$32.2 million in Q4 2024.
• A 5-year average of -$15.2 million and a median of -$18.6 million in 2023 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2023 and 2025: Change in Inventory tumbled 762.95% in 2023, then soared 110.35% in 2025.
• Over 5 years, Change in Inventory stood at -$27.2 million in 2022, then climbed by 21.79% to -$21.3 million in 2023, then slumped by 51.37% to -$32.2 million in 2024, then soared by 101.81% to $583185.8 in 2025, then tumbled by 2672.21% to -$15.0 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered -$15.0 million, $583185.8, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.